CONMED Corp — Director's Dealing 2023

Mar 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-03-01

Reporting Person: Hartman Curt R (Director, President, CEO and Chair)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Options To Purchase Common Stock	$96.16	A	67141	Acquired	2033-03-01	Common Stock (67141)	Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period